Corisma
Hamden, US · Founded 2018 · 1 known investors
Find your way into Corisma
Corisma develops a fully implanted transcatheter mechanical circulatory support system for advanced heart failure patients, designed to bridge acute and chronic care with improved quality of life. The device eliminates the driveline and uses wireless, catheter-based technology to replace current standard-of-care treatment options.
Founders & leadership
RW
R. William VogelinChief Executive Officer
YZ
Yuhang ZhaoNamed on SEC filing
MT
Michael TheranNamed on SEC filing
Board
KM
Kaushik MandalChairman
Investors · 1
Reported raises · per SEC filings
Form D private placements$5.2M disclosed across 1 round · 2021
▶$5.2MraisedAug 2021 · 24 investors · BiotechnologyRule 506(b)
▶$5.2MraisedAug 2021 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yuhang ZhaoDirector
- Michael TheranExecutive Officer, Director
- Offering amount
- $14M
- Amount sold
- $5.2M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Corisma do?
- Corisma develops a fully implanted transcatheter mechanical circulatory support system for advanced heart failure patients, designed to bridge acute and chronic care with improved quality of life. The device eliminates the driveline and uses wireless, catheter-based technology to replace current standard-of-care treatment options.
- Who are Corisma's investors?
- Corisma's investors include Connecticut Innovations.
- How much funding has Corisma raised?
- Corisma has disclosed $5.2M raised across 1 round.
- Where is Corisma headquartered?
- Corisma is headquartered in Hamden, US.